Protagenic Therapeutics, Inc.\new (PTIX) Share-based Compensation (2015 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) reported Share-based Compensation of $95,942 for fiscal Q3 2026 (quarter ended Dec 31, 2025).
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Share-based Compensation (2015 - 2026) Analysis & Trends
Over the twelve months ended Dec 31, 2025, Protagenic Therapeutics, Inc.\new's Share-based Compensation came in at $827,795; for FY2025 (ended Mar 31, 2025), it came in at $236,014.
- Share-based Compensation has a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
- By fiscal year, Share-based Compensation came in at $923,139 in FY2024 (+38.4%), $666,828 in FY2023 (-22.9%), $864,681 in FY2022 (-43.1%) and $1.52 million in FY2021 (-8.2%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Share-based Compensation since fiscal Q3 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | 67,012.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 67,012.00 |
| Mar 31, 2026 | 91,652.00 |
| Dec 31, 2025 | 95,942.00 |
| Sep 30, 2025 | 105,868.00 |
| Jun 30, 2025 | 125,127.00 |
| Mar 31, 2025 | 236,014.00 |
| Dec 31, 2024 | 245,436.00 |
| Sep 30, 2024 | 250,403.00 |
| Jun 30, 2024 | 265,439.00 |
| Mar 31, 2024 | 161,861.00 |
| Dec 31, 2023 | 166,707.00 |
| Sep 30, 2023 | 166,707.00 |
| Jun 30, 2023 | 166,707.00 |
| Mar 31, 2023 | 166,707.00 |
| Dec 31, 2022 | 198,688.00 |
| Sep 30, 2022 | 214,679.00 |
| Jun 30, 2022 | 215,535.00 |
| Mar 31, 2022 | 235,779.00 |
| Dec 31, 2021 | 218,166.00 |
| Sep 30, 2021 | 231,649.00 |
API Access
Protagenic Therapeutics, Inc.\new Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();